New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
Cary O HardingDepartments of Molecular and Medical Genetics and Pediatrics, Oregon Health & Science University, Portland, Oregon, USAAbstract: Oral administration of sapropterin hydrochloride, recently approved for use by the US Food and Drug Administration and the European Commission, i...
Guardado en:
Autor principal: | Cary O Harding |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ad2204159d240fd8108f9cd8765077a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Alberto Burlina, et al.
Publicado: (2021) -
A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials
por: Barbara K. Burton, et al.
Publicado: (2021) -
Evaluation of Nutritional Status and Growth in Phenylketonuria Patients in Mazandaran Province Iran
por: Eshraghi P, Abbaskhanian A, Bijani A, Hosseinzadeh S
Publicado: (2011) -
A new era of cancer treatment: carbon nanotubes as drug delivery tools
por: Madani SY, et al.
Publicado: (2011) -
Launch of a new journal, beginning of a new era
Publicado: (2015)